Area of research
Cancer Research · Hematology
Research interest
Research interests include Cancer research, Daratumumab, CD38, Myeloid leukemia, Leukemia, and Immune system.
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages
Daratumumab induces CD38 internalization and impairs myeloma cell adhesion
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome